Generic drugs

These companies make and sell generic medicines whose patents have expired, competing on volume and price.
+30.2%
over 6 months · S&P 500 +2.6%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 41
Cheap
Expensive
Up over 1 year
6 of 9
Volatility
33%
Calm
Choppy
Health and price: against the other tags.